The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats

NeuroImmunoModulation

Volumn 1, Issue 1, 1994, Pages 28-32

  Ceriani, Giuliana ^a   Diaz, Julie ^a   Murphree, Sidney ^a   Catania, Anna ^c   Lipton, James M ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Adjuvant arthritis; Inflammation; Neuroimmunomodulation; Neuropeptide; Prednisolone; Steroid induced weight loss; Melanocyte stimulating hormone

Indexed keywords

ALPHA INTERMEDIN; NEUROPEPTIDE; PREDNISOLONE; SODIUM CHLORIDE;

ANIMAL; ARTICLE; BODY WEIGHT; DISEASE MODEL; DRUG EFFECT; INFECTIOUS ARTHRITIS; INFLAMMATION; MALE; RAT; SPRAGUE DAWLEY RAT; TIME;

ALPHA-MSH; ANIMALS; ARTHRITIS, INFECTIOUS; BODY WEIGHT; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; NEUROPEPTIDES; PREDNISOLONE; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHLORIDE; TIME FACTORS;

EID: 0028366845     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097087     Document Type: Article

References (32)

1. Catania A, Lipton JM: a-Melanocyte stimulating hormone in the modulation of host reactions. Endocr Rev, in press.
2. Lipton JM, Catania A: aMSH peptides modulate fever and inflammation; in Bartfai T, Ottoson D (eds): Neuro-Immunology of Fever. New York. Pergamon 1992, pp 123-136.
3. Catania A, Lipton JM: α-MSH peptides in host responses: From basic evidence to human research; in Vaudry H, Everle AN (eds): The Melanotropic Peptides. New York, New York Academy of Sciences, 1992, pp 608-625.
4. Lipton JM, Catania A: Pyrogenic and inflammatory actions of cytokines and their modulation by neuropeptides: Techniques and interpretations; in DeSouza EB (ed): Neurobiology of Cytokines. Orlando, Academic Press, in press.
5. Hiltz ME, Catania A, Lipton JM: α-MSH peptides inhibit acute inflammation induced in mice by rIL-l, rIL-6, rTNF-α and endogenous pyrogen but not that caused by LTB4, PAF and rIL-8. Cytokine 1992;4:320-328.
6. Watanabc T, Hiltz ME, Catania A, Lipton JM: Inhibition of IL-lβ-induced peripheral inflammation by peripheral and central administration of analogs of the neuropeptide α-MSH. Br Res Bull 1993, in press.
7. Ceriani G, Macaluso A, Catania A, Lipton JM: Central neurogenic antiinflammatory action of a-MSH: Modulation of peripheral inflammation induced by cytokines and other mediators of inflammation. Neuroendocrinology, submitted.
8. Taylor AW, Streilein JW, Cousins SW: Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res 1992;11:1199-1206.
9. Luger TA, Schauer E, Trautinger F, Krutmann J, Ansel J, Schwarz A, Schwarz T: Production of immunosuppressing melanotropins by human kerationocytes; in Vaudry H, Eberle AN (eds): The Melanotropic Peptides. New York, New York Academy of Sciences, 1992, pp 567-570.
10. Lipton JM, Macaluso A, Hiltz ME, Catania A: Central administration of the peptide a-MSH inhibits inflammation in the skin. Peptides 1991;12:795-798.
11. Catania A, Arnold J, Macaluso A, Hiltz ME, Lipton JM: Inhibition of acute inflammation in the periphery by central action of salicylates. Proc Natl Acad Sci USA 1991;88:8544-8547.
12. Macaluso A, McCoy D, Ceriani G, Watanabc T, Biltz J, Catania A, Lipton JM: Antiinflammatory influences of a-MSH molecules: Central neurogenic and peripheral actions. J Neuroscience, submitted.
13. Mason MJ, Van Epps D: Modulation of IL-1, tumor necrosis factor, and C5a-mcdiated murine neutrophil migration by α-melanocyte-stimulating hormone. J Immunol 1989;142:1646-1651.
14. Hopkins SJ: Cytokines and their significance in rheumatic disease; in Orme M (ed): Anti-Rheumatic Drugs. New York, Pergamon 1990, pp 49-118.
15. Stoerk HC, Bielinski TC, Budzilovich T: Chronic polyarthritis in rats injected with spleen in adjuvants. Am J Pathol 1954;30:616-620.
16. Pearson CM, Wood FD: Studies of polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvantI General clinical and pathologic characteristics and some modifying factors. Arthritis Rheum 1959;2:440-459.
17. Newbould BB: Chemotherapy of arthritis induced in rats by mycobacterial adjuvant Br J Pharmacol 1963;21:127-136.
18. Billingham MEJ: Models of arthritis and the search for anti-arthritic drugs; in Orme M(ed): Anti-Rheumatic Drugs. New York, Pergamon, 1990, pp 1-47.
19. Lipton JM: MSH in CNS control of fever and its influence on inflammation/immune responses; in Hadley ME (ed): The Melanotropic Peptides. Boca Raton, CRC Press, 1988, vol 2, pp 97-113.
20. Lipton JM: Neuropeptide alpha-melanoeyte stimulating hormone in control of fever, the acute phase response and inflammation; in Goetzl EJ, SpEcctor NH (eds): Neuroimmune Networks: Physiology and Diseases. New York, Alan R. Liss, 1989, pp 243-250.
21. Hiltz ME, Lipton JM: Antiinflammatory activity of a COOH-tcrminal fragment of the neuropeptide α-MSH. FASEB J 1989;3:2282-2284.
22. Hiltz ME, Lipton JM: Alpha-MSH peptides inhibit acute inflammation and contact hypersensitivity. Peptides 1990;11:972-982.
23. Rheins LA, Cotlcur AL, KlEiEr RS, HoppEnjans WB, Saunder DN, Nordlund JJ: Alpha-melanocyte stimulating hormone modulates contact hypersensitivity responsiveness in C57/BL6 mice. J Invest Dermatol 1989;93:511-517.
24. Waalen K, Sioud M, Natvig JB, Forre O: Spontaneous in vivo gene transcription of interleukin-2, interleukin-3, interlcukin-4, interleukin- 6, interferon-gamma, interlcukin-2 receptor (CD25) and proto-oncogene c-myc by rheumatoid synovial T lymphocytes. Scand J Immunol 1992;36:865-873.
25. Chu CQ, Field M, Allard S, Abney E, Feldman M, Maini RN: Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: Implications for the role of cytokines in cartilage destruction and repair. BrJ Rheumatol 1992;31:653-661.
26. Kowanko IC, Ferrante A: Interferon-gamma increases human neutrophil-mediated cartilage proteogycan degradation. Clin Exp Rheumatol 1992;10:123-129.
27. Holt I, Cooper RG, Denton J, Meager A, Hopkins SJ: Cytokine inter-relationships and their association with disease activity in arthritis. Br J Rheumatol 1992;31:725-733.
28. German Lymphokine Study Group: Double blind controlled phase III multicentEr clinical trial with interferon gamma in rheumatoid arthritis. Rheumatol 1992;12:175-185.
29. Glenn EM: Adjuvant-induced arthritis: Effects of certain drugs on incidence, clinical severity, and biological changes. Am J Vet Med 1966;27:339-352.
30. Shafagoj Y, Opoku J, Qureshi D, REgElson W, Lalami M: Dchydrocpiandrostcrone prevents dexamcthasone-induced hypertension in rats. Am J Physiol 1992;263:E210-E213.
31. Thorn GW; Clinical considerations in the use of corticosteroids. N Engl J Med 1966;274:775-781.
32. David DS, Grieco MH, Cushman P Jr: Adrenal glucocorticoids after twenty years: a review of their clinically relevant consequences. J Chronic Dis 1970;22:637-711.